Success Metrics

Clinical Success Rate
33.3%

Based on 1 completed trials

Completion Rate
33%(1/3)
Active Trials
3(38%)
Results Posted
0%(0 trials)
Terminated
2(25%)

Phase Distribution

Ph not_applicable
1
13%
Ph phase_4
3
38%
Ph phase_2
1
13%
Ph phase_3
2
25%

Phase Distribution

0

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
2(28.6%)
Phase 4Post-market surveillance
3(42.9%)
N/ANon-phased studies
1(14.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

3

trials recruiting

Total Trials

8

all time

Status Distribution
Active(3)
Completed(1)
Terminated(2)
Other(2)

Detailed Status

Recruiting3
unknown2
Terminated2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
3
Success Rate
33.3%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 32 (28.6%)
Phase 43 (42.9%)
N/A1 (14.3%)

Trials by Status

completed113%
recruiting338%
unknown225%
terminated225%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8